These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17445210)

  • 1. Association of killer immunoglobulin-like receptors and their HLA Class I ligands with progression of chronic hepatitis C virus infection.
    López-Vázquez A; Rodrigo L; López-Larrea C
    Tissue Antigens; 2007 Apr; 69 Suppl 1():241-2. PubMed ID: 17445210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of inhibitory killer immunoglobulin-like receptors and their HLA-C ligands on resolving hepatitis C virus infection.
    Rauch A; Laird R; McKinnon E; Telenti A; Furrer H; Weber R; Smillie D; Gaudieri S;
    Tissue Antigens; 2007 Apr; 69 Suppl 1():237-40. PubMed ID: 17445209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunology. NK cells lose their inhibition.
    Parham P
    Science; 2004 Aug; 305(5685):786-7. PubMed ID: 15297654
    [No Abstract]   [Full Text] [Related]  

  • 4. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
    de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
    Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of the HLA-Bw4I80 epitope and the killer cell immunoglobulin-like receptor 3DS1 gene against the development of hepatocellular carcinoma in patients with hepatitis C virus infection.
    López-Vázquez A; Rodrigo L; Martínez-Borra J; Pérez R; Rodríguez M; Fdez-Morera JL; Fuentes D; Rodríguez-Rodero S; Gonzáez S; López-Larrea C
    J Infect Dis; 2005 Jul; 192(1):162-5. PubMed ID: 15942906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased frequencies of activating natural killer receptors are associated with liver injury in individuals who do not eliminate hepatitis C virus.
    Paladino N; Flores AC; Marcos CY; Fainboim H; Theiler G; Arruvito L; Williams F; Middleton D; Fainboim L
    Tissue Antigens; 2007 Apr; 69 Suppl 1():109-11. PubMed ID: 17445180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus and the threshold of natural killer cell inhibition.
    Ahlenstiel G; Rehermann B
    Hepatology; 2005 Mar; 41(3):675-7. PubMed ID: 15723330
    [No Abstract]   [Full Text] [Related]  

  • 8. Hanging in the balance. KIR and their role in disease.
    Williams AP; Bateman AR; Khakoo SI
    Mol Interv; 2005 Aug; 5(4):226-40. PubMed ID: 16123537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the genetic restriction of virus-specific T-cell responses in hepatitis C virus infection.
    Neumann-Haefelin C; Thimme R
    Genes Immun; 2007 Apr; 8(3):181-92. PubMed ID: 17230195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolutionary vignettes of natural killer cell receptors.
    Sambrook JG; Beck S
    Curr Opin Immunol; 2007 Oct; 19(5):553-60. PubMed ID: 17884420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer cell crossmatch: functional analysis of inhibitory killer immunoglobulin-like receptors and their HLA ligands.
    Han M; Fallena M; Guo Y; Stastny P
    Hum Immunol; 2007 Jun; 68(6):507-13. PubMed ID: 17509450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MICA and recovery from hepatitis C virus and hepatitis B virus infections.
    Karacki PS; Gao X; Thio CL; Thomas DL; Goedert JJ; Vlahov D; Kaslow RA; Strathdee S; Hilgartner MW; O'Brien SJ; Carrington M
    Genes Immun; 2004 Jun; 5(4):261-6. PubMed ID: 15029237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimpanzee susceptibility to hepatitis C virus infection correlates with presence of Pt-KIR3DS2 and Pt-KIR2DL9: paired activating and inhibitory natural killer cell receptors.
    Abi-Rached L; Guethlein LA; Norman PJ; Parham P
    Immunogenetics; 2015 Oct; 67(10):625-8. PubMed ID: 26260270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA class I recognition by killer cell Ig-like receptors.
    Long EO; Rajagopalan S
    Semin Immunol; 2000 Apr; 12(2):101-8. PubMed ID: 10764618
    [No Abstract]   [Full Text] [Related]  

  • 15. The human natural killer lymphocyte receptors for MHC class I molecules.
    Bensussan A
    Eur Cytokine Netw; 1998 Dec; 9(4):577-83. PubMed ID: 9889401
    [No Abstract]   [Full Text] [Related]  

  • 16. Having it both ways: MHC recognition in cis and trans.
    Leibson PJ; Pease LR
    Nat Immunol; 2004 Mar; 5(3):237-8. PubMed ID: 14985707
    [No Abstract]   [Full Text] [Related]  

  • 17. Understanding the role of natural killer cell receptors and their human leukocyte antigen ligands in multiple sclerosis.
    Trachtenberg EA
    Ann Neurol; 2009 Jun; 65(6):626-8. PubMed ID: 19557875
    [No Abstract]   [Full Text] [Related]  

  • 18. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection.
    Khakoo SI; Thio CL; Martin MP; Brooks CR; Gao X; Astemborski J; Cheng J; Goedert JJ; Vlahov D; Hilgartner M; Cox S; Little AM; Alexander GJ; Cramp ME; O'Brien SJ; Rosenberg WM; Thomas DL; Carrington M
    Science; 2004 Aug; 305(5685):872-4. PubMed ID: 15297676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MHC class I molecules and KIRs in human history, health and survival.
    Parham P
    Nat Rev Immunol; 2005 Mar; 5(3):201-14. PubMed ID: 15719024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cells, killer immunoglobulin-like receptors and human leucocyte antigen class I in disease.
    Boyton RJ; Altmann DM
    Clin Exp Immunol; 2007 Jul; 149(1):1-8. PubMed ID: 17521317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.